Roughly one in three men who try sildenafil, tadalafil, or another PDE5 inhibitor either can’t take it safely, doesn’t respond to it, or simply refuses to live on a pill schedule. For that audience, 2026 is the best year on record. The FDA cleared the first over-the-counter ED treatment (Eroxon) in 2023, shockwave therapy has matured into a credible mid-tier option, and inflatable penile implants now post 95% satisfaction rates that no oral drug can match.

This guide compares seven non-pill modalities head-to-head: shockwave therapy, intracavernosal injections, vacuum erection devices, penile implants, P-Shot/PRP, Eroxon topical gel, and structured lifestyle programs. No PDE5 pills are recommended here. If you want a pill-based comparison, that lives on a different page.

Key takeaways for 2026

Eroxon (FDA cleared 2023): The only OTC, non-prescription ED treatment in the United States. Onset in 10 minutes, ~$20-30 per 4-pack.
Alprostadil/Caverject (FDA approved 1995): Still the gold-standard rescue therapy when pills fail; 70-80% response rate.
Vacuum erection devices (FDA cleared since the 1980s): Cheapest reliable mechanical option, often covered by Medicare for diagnosed ED.
Inflatable penile prosthesis (FDA approved 1973, current AMS 700 / Coloplast Titan iterations): 95% patient and partner satisfaction in long-term cohort studies.
Low-intensity shockwave therapy (Li-ESWT): Still “investigational” per the 2024 AUA/SMSNA guideline update, but clinic-grade evidence in mild-to-moderate vasculogenic ED.
P-Shot/PRP: No FDA approval for ED indication as of 2026; treat as experimental.
Lifestyle interventions: The most under-prescribed effective therapy on this list, with Cochrane-level evidence for aerobic exercise.

Why some men can’t or won’t take ED pills

The pill-free audience isn’t fringe. It’s defined by five distinct populations, and most clinicians underestimate how large it is.

Nitrate users (absolute medical contraindication)

Anyone on nitroglycerin, isosorbide mononitrate, or isosorbide dinitrate for angina or heart failure cannot safely use any PDE5 inhibitor. The combination produces life-threatening hypotension. The American College of Cardiology lists this as a hard contraindication, no exceptions. For these men, every option on this page is on the table; pills are not.

PDE5 non-responders (~30% of users)

Real-world response rates to sildenafil and tadalafil hover between 60% and 70% in unselected men, and drop further in diabetics, post-prostatectomy patients, and men with severe vasculogenic ED. That leaves a substantial minority for whom pills genuinely don’t work, even at maximum dose with optimized timing.

Cardiovascular risk and alpha-blocker interactions

Men on multiple antihypertensives, especially alpha-blockers like tamsulosin or doxazosin, often experience orthostatic hypotension on PDE5 inhibitors. Cardiologists frequently recommend non-pill alternatives in this group.

Side-effect intolerance

Headache, flushing, nasal congestion, dyspepsia, and visual disturbances cause roughly 15-20% of users to discontinue pills within a year. Non-pill modalities sidestep systemic side effects entirely.

Personal preference and pill fatigue

Some men simply don’t want another daily medication, dislike the “scheduling” feel of on-demand dosing, or carry stigma around ED prescriptions. Pill-free options give them ownership of the treatment.

Shockwave therapy (Li-ESWT / GAINSWave)

Low-intensity extracorporeal shockwave therapy delivers focused acoustic pulses to penile tissue. The proposed mechanism is angiogenesis: micro-trauma triggers vascular endothelial growth factor (VEGF) release, recruiting new blood vessels into cavernosal tissue. In theory, this addresses the root cause of vasculogenic ED rather than masking it the way pills do.

Evidence and regulatory status

The 2024 AUA/SMSNA guideline addendum acknowledges Li-ESWT as a promising therapy but categorizes it as “investigational” pending larger sham-controlled trials. Multiple meta-analyses (Clavijo 2017, Lu 2017, Sokolakis 2019) report statistically significant IIEF-EF improvements in mild-to-moderate vasculogenic ED, with effect sizes diminishing in severe ED and diabetic cohorts. The European Association of Urology (EAU) lists Li-ESWT as a recommended option for mild vasculogenic ED, which is more permissive than the US guidance.

Cost, providers, and realistic expectations

A standard protocol is 6 to 12 sessions, $300-$600 each, totaling $3,000-$6,000. Effectiveness in published series runs 60-70% for mild-to-moderate ED, with durability of 12-24 months before potential re-treatment. The GAINSWave network is the largest US franchise, but quality varies wildly by clinic; university-affiliated urology centers tend to use the most rigorous protocols and the better-validated machines (Storz Duolith, Direx Renova).

Red flags: any clinic promising 95% cure rates, pushing 20+ sessions, or bundling shockwave with unrelated “wellness” services. Insurance does not cover Li-ESWT in 2026 because of the investigational label.

Penile injections (Trimix, papaverine, alprostadil)

Intracavernosal injection therapy is the most effective non-surgical ED treatment ever developed. Self-administered with a fine needle into the side of the shaft 10-15 minutes before sex, it produces erections in 70-80% of men, including those for whom pills fail completely.

The three drugs

Alprostadil (Caverject, Edex): The only FDA-approved injectable for ED. ~$100 per dose. Single agent, more predictable, slightly more burning at the injection site.
Papaverine: Older smooth-muscle relaxant, usually compounded with phentolamine (“Bimix”).
Trimix: Compounded alprostadil + papaverine + phentolamine. Lower individual drug doses, often better tolerated. ~$30-60 per dose from a compounding pharmacy.

Learning curve and risks

Most patients need one or two in-clinic teaching sessions. Dose titration matters: too little does nothing, too much risks priapism, defined as an erection lasting more than four hours. Priapism is a urological emergency and the single most important reason to start with the lowest effective dose. Long-term injection users may develop fibrotic nodules at injection sites.

Online access

Several telehealth platforms (Hims, Ro, and specialty compounding services) now ship Trimix after a video consultation, with the first dose typically administered or witnessed by a clinician in person or via guided telehealth.

Vacuum erection devices (VEDs)

The most under-appreciated treatment on this list. A vacuum erection device creates negative pressure around the penis, drawing blood in mechanically, then a constriction ring at the base traps the blood for intercourse. No drugs, no needles, no interactions.

Medical-grade vs novelty devices

This distinction is critical. FDA-cleared medical VEDs have pressure-limiting valves to prevent injury. Novelty “pumps” sold for cosmetic enhancement do not, and they account for most pump-related injuries reported to ERs.

FDA-cleared brands worth knowing:

Pos-T-Vac: The traditional medical standard, often prescribed post-prostatectomy.
Encore Deluxe / Encore Medical: Battery-powered with pressure limits, Medicare-billable.
Bathmate Hydromax: Water-based, popular for daily rehab use; FDA-registered.
Vacurect: One-piece design for easier handling.

Cost and use cases

$200-$500 one-time purchase. Medicare Part B often covers a prescribed VED for documented ED. Post-prostatectomy rehabilitation is the strongest indication: daily VED use in the months after radical prostatectomy is associated with better preservation of penile length and earlier return of natural erections.

Downsides

Erections feel slightly cooler and may pivot at the base because the ring sits outside the body. The prep ritual (2-5 minutes) breaks spontaneity. Ring constriction is uncomfortable for some men and must be removed within 30 minutes.

Penile implants (penile prosthesis)

The most effective ED treatment ever invented, and the most invasive. A penile implant is a surgically placed device that replaces the function of the corpora cavernosa.

Two main types

Malleable (semi-rigid): Bendable rods. Simpler surgery, lower cost, easier for men with poor hand dexterity. Permanently semi-firm.
Inflatable 3-piece (AMS 700, Coloplast Titan): Cylinders in the penis, a pump in the scrotum, a reservoir in the abdomen. Squeeze to inflate, press a release valve to deflate. Most natural appearance and function.

Outcomes

Long-term satisfaction studies (Carvajal 2020, Bernal 2020) report 90-95% patient satisfaction and ~90% partner satisfaction at 5-10 year follow-up, the highest of any ED treatment. Device survival is roughly 80% at 10 years for current-generation inflatable models. Infection rate with modern antibiotic-coated implants is 1-2%.

Cost and insurance

Out-of-pocket cost is $25,000-$30,000 including surgeon, anesthesia, and hospital fees. However, most major insurers (including Medicare) cover penile prosthesis for medically diagnosed ED that has failed less invasive treatments. The “step therapy” requirement varies by plan but typically includes documented failure of PDE5 inhibitors plus one other modality.

Where to get it

This is a procedure where surgeon volume matters enormously. High-volume implant centers (often academic urology departments and a handful of private practices doing 100+ implants/year) have markedly lower infection and revision rates. The Sexual Medicine Society of North America maintains a referral directory.

P-Shot (platelet-rich plasma injection)

The P-Shot, a trademarked name for intracavernosal PRP injection, is the most aggressively marketed and least well-supported treatment on this list.

What it is

Blood is drawn, centrifuged to concentrate platelets, and the resulting PRP is injected into the penis under local anesthesia. The proposed mechanism is growth-factor-mediated tissue regeneration.

The evidence problem

As of 2026, the FDA has not approved PRP for any ED indication. Published trials are small, often unblinded, frequently industry-affiliated, and inconsistent in protocol. A handful of small RCTs show modest IIEF-EF improvements; others show no benefit beyond placebo. The 2024 AUA guideline addendum explicitly recommends against routine clinical use of PRP for ED outside of research settings.

Cost and buyer-beware framing

$1,500-$2,500 per injection, typically sold in 3-shot packages ($4,500-$7,500). If a clinic claims FDA approval for the P-Shot, that’s a misrepresentation. PRP itself is a regulated biologic; the marketing label “P-Shot” is not an approved indication. For men who want regenerative therapy, shockwave has more evidence at lower cost.

Eroxon topical gel (FDA-cleared OTC, 2023)

Eroxon is the first and only over-the-counter ED treatment cleared by the FDA. The clearance, granted in June 2023, was significant because it removed the prescription barrier for the first time in the history of ED therapy.

Mechanism

Eroxon is a topical gel applied directly to the glans. It contains volatile solvents that produce rapid evaporative cooling followed by warming. The thermal stimulus is hypothesized to activate sensory nerves, triggering the local nitric oxide pathway and smooth muscle relaxation. Crucially, it contains no PDE5 inhibitor and no hormone, so it has no systemic drug interactions.

Evidence

Two pivotal trials submitted to the FDA reported that 60-65% of men achieved an erection sufficient for intercourse within 10 minutes of application, with subgroups (mild ED) reaching the 80-87% range cited in marketing materials. Onset was the standout result: most responders erected within 10 minutes, faster than sildenafil.

Cost and access

$20-30 per 4-tube pack (each tube is one dose). Available at CVS, Walgreens, Amazon, and Eroxon’s direct site. No prescription, no telehealth consult, no insurance hassle. The trade-off is efficacy: it works less reliably than injections or implants, especially in moderate-to-severe ED.

Sublingual troches and oral disintegrating tablets

A note on a hybrid category that some men consider “non-pill” even though it is technically still a PDE5 inhibitor. Compounded sublingual troches and orally disintegrating tablets (ODTs) dissolve under the tongue or on the cheek and absorb through the oral mucosa, bypassing first-pass liver metabolism.

If you strictly avoid PDE5 drugs, this category does not apply. If your objection is to swallowing pills (texture, scheduling, gag reflex) rather than to the drug class itself, troches offer faster onset (often 15-20 minutes vs 30-60 for tablets) and can be discreet. They are prescription-only and typically compounded.

Lifestyle interventions that actually work for ED

The most under-prescribed effective ED therapy is structured lifestyle change. Several interventions have evidence comparable to first-line drug therapy in appropriate populations.

Pelvic floor physical therapy

A 2005 BJU International RCT (Dorey et al.) found 40% of men with ED achieved normal erectile function after 3 months of pelvic floor muscle training, with another 35% improved. Specialized male pelvic floor physical therapists (not general PTs) deliver the highest-quality care. Roughly $100-200 per session, 6-12 sessions typical.

Aerobic exercise

A 2018 Cochrane review and a 2018 meta-analysis (Gerbild et al.) concluded that 40 minutes of moderate-to-vigorous aerobic exercise four times weekly produces clinically meaningful IIEF-EF score improvements within 6 months, with effect sizes approaching those of low-dose tadalafil in mild ED. Free, no side effects, multiple secondary benefits.

Weight loss

A randomized trial in JAMA (Esposito 2004) demonstrated that men with obesity and ED who lost 10% of body weight via diet and exercise had significant improvements in IIEF-EF scores compared with controls.

Sleep apnea treatment

Undiagnosed obstructive sleep apnea is one of the most overlooked causes of ED. Multiple cohort studies show substantial erectile function improvement within 3-6 months of starting CPAP therapy in men with moderate-to-severe OSA. If you snore, wake unrefreshed, or have a thick neck plus ED, a sleep study is the highest-yield workup.

Mediterranean diet

Observational and interventional studies consistently associate Mediterranean dietary pattern adherence with lower ED prevalence and improved IIEF scores, mediated through endothelial function and inflammation.

Cost comparison: 5-year total cost of ownership

Looking at 5-year costs reframes the conversation. Pills look cheap on a per-dose basis but compound over time; capital-cost devices look expensive upfront but flatten out.

PDE5 pills (generic, reference only): $1,500-$3,000 over 5 years depending on frequency and brand.
Eroxon OTC gel (2/week): ~$3,000-$4,000 over 5 years.
Vacuum erection device: $300-$500 one-time, plus replacement rings ($30/year). 5-year total: ~$500.
Trimix injections (2/week): ~$6,000-$12,000 over 5 years.
Shockwave therapy: $4,500 initial + likely one re-treatment course ~$3,000. 5-year total: ~$7,500.
P-Shot (annual): $7,500-$12,500 over 5 years for speculative benefit.
Penile implant: $25,000-$30,000 once, often largely insurance-covered. Insured 5-year cost can be under $5,000 out-of-pocket.

For men with severe, treatment-resistant ED, the math frequently favors the vacuum device (cheapest) or the penile implant (most effective for long-term value) over years of injection therapy or repeated shockwave courses.

When to choose pill-free ED treatment

A simplified decision framework:

On nitrates or absolute pill contraindication: Start with Eroxon (mild ED) or vacuum device (any severity). Escalate to injections if needed. Consider implant for severe, durable ED.
Pills tried and failed: Injection therapy is the highest-yield next step. Vacuum devices in parallel. Shockwave if vasculogenic and mild-to-moderate.
Pill side effects intolerable: Eroxon (lowest barrier), then vacuum device, then injections.
Personal preference, mild ED, want OTC: Eroxon + lifestyle program (pelvic floor PT, aerobic exercise, sleep evaluation).
Severe, durable ED, partner-coordinated decision: Penile implant consultation at a high-volume center.
Post-prostatectomy: Vacuum device daily for rehabilitation, plus injection therapy as needed; implant if no recovery at 18-24 months.

Frequently asked questions

Are non-pill ED treatments FDA-approved?

Some are, some aren’t. FDA-approved or FDA-cleared: alprostadil injection (Caverject, Edex), Eroxon OTC gel, medical-grade vacuum erection devices, penile implants. Not FDA-approved for ED: shockwave therapy (Li-ESWT) and P-Shot/PRP, both considered investigational in 2026.

Is GAINSWave a scam?

GAINSWave is a marketing network of clinics offering Li-ESWT. The underlying therapy is legitimate and has published evidence, but quality varies dramatically across the network. Look for clinics using validated devices (Storz Duolith, Direx Renova), urologist or sexual medicine physician supervision, and standardized 6-12 session protocols. Avoid any clinic promising guaranteed results, bundling unrelated services, or requiring large upfront payments before any treatment.

Do penis pumps actually work?

Yes, when you use an FDA-cleared medical vacuum erection device. Real-world success rates run 70-90% for producing an erection adequate for intercourse, including in men who fail pills. The mechanism is purely mechanical, so there are no drug interactions. Novelty “enhancement” pumps without pressure regulators are a different category and can cause injury.

How long do penile implants last?

Modern inflatable implants (AMS 700, Coloplast Titan) have approximately 80% device survival at 10 years and 60-70% at 15 years. Many men keep their original implant for 15-20+ years. When mechanical failure occurs, revision surgery to replace the device is straightforward and has similar satisfaction outcomes.

Can I get a penile injection prescription online?

Yes. Several telehealth platforms now prescribe Trimix and alprostadil after a video consultation. Most require an initial in-person or telehealth-guided test dose so the clinician can verify technique and titrate dose. Compounded Trimix typically ships from a partnered compounding pharmacy.

Is Eroxon really available over-the-counter?

Yes. Eroxon was FDA-cleared as an OTC product in June 2023 and is on shelves at CVS, Walgreens, and online retailers including Amazon. No prescription, no telehealth visit, and no age verification beyond standard retail policies are required.

What’s the cheapest non-pill ED treatment?

Structured lifestyle change (aerobic exercise, weight loss, sleep apnea workup) is free or near-free and has Cochrane-level evidence in appropriate populations. Among devices, a medical-grade vacuum erection device at $200-$500 one-time is by far the cheapest durable hardware option, often covered by Medicare with documentation.

Does insurance cover non-pill ED treatments?

Variable. Vacuum devices and penile implants are frequently covered for medically diagnosed ED, especially under Medicare and many commercial plans after documented failure of pills. Injectable alprostadil is often covered. Shockwave therapy and P-Shot are not covered. Eroxon is OTC and not typically reimbursed.

Medical disclaimer and affiliate disclosure

This article is for informational purposes only and does not constitute medical advice. ED can be the first symptom of cardiovascular disease, diabetes, or hormonal disorders; any new or worsening erectile dysfunction warrants evaluation by a licensed clinician. Discuss every treatment on this page with a urologist or men’s health physician before starting.

Most of the non-pill options described here are not affiliate-monetized on this site. Where we recommend a telehealth platform for evaluation (for injection prescriptions, troches, or initial workup), we may earn a referral fee at no additional cost to you. Our editorial selections are based on FDA status, published evidence, and clinical guideline alignment, not commission rates.